annual D&A:
$97.00M+$66.10M(+213.97%)Summary
- As of today (July 26, 2025), ABCL annual depreciation & amortization is $97.00 million, with the most recent change of +$66.10 million (+213.97%) on December 31, 2024.
- During the last 3 years, ABCL annual D&A has risen by +$79.75 million (+462.31%).
- ABCL annual D&A is now at all-time high.
Performance
ABCL Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$6.61M-$7.29M(-52.48%)Summary
- As of today (July 26, 2025), ABCL quarterly depreciation & amortization is $6.61 million, with the most recent change of -$7.29 million (-52.48%) on March 31, 2025.
- Over the past year, ABCL quarterly D&A has dropped by -$161.00 thousand (-2.38%).
- ABCL quarterly D&A is now -82.75% below its all-time high of $38.30 million, reached on September 30, 2024.
Performance
ABCL quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$96.84M-$161.00K(-0.17%)Summary
- As of today (July 26, 2025), ABCL TTM depreciation & amortization is $96.84 million, with the most recent change of -$161.00 thousand (-0.17%) on March 31, 2025.
- Over the past year, ABCL TTM D&A has increased by +$66.30 million (+217.08%).
- ABCL TTM D&A is now -0.17% below its all-time high of $97.00 million, reached on December 31, 2024.
Performance
ABCL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABCL Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +214.0% | -2.4% | +217.1% |
| 3 y3 years | +462.3% | +32.8% | +430.4% |
| 5 y5 years | +5151.6% | +922.5% | +5510.5% |
ABCL Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +462.3% | -82.8% | +9.3% | -0.2% | +382.2% |
| 5 y | 5-year | at high | +5151.6% | -82.8% | +604.9% | -0.2% | +5510.5% |
| alltime | all time | at high | >+9999.0% | -82.8% | +922.5% | -0.2% | >+9999.0% |
ABCL Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $6.61M(-52.5%) | $96.84M(-0.2%) |
| Dec 2024 | $97.00M(+214.0%) | $13.90M(-63.7%) | $97.00M(+5.2%) |
| Sep 2024 | - | $38.30M(+0.7%) | $92.21M(+50.4%) |
| Jun 2024 | - | $38.04M(+462.2%) | $61.32M(+100.8%) |
| Mar 2024 | - | $6.77M(-25.7%) | $30.54M(-1.1%) |
| Dec 2023 | $30.89M(-6.7%) | $9.11M(+22.9%) | $30.89M(-16.8%) |
| Sep 2023 | - | $7.41M(+2.1%) | $37.15M(+1.9%) |
| Jun 2023 | - | $7.26M(+1.9%) | $36.46M(+3.4%) |
| Mar 2023 | - | $7.12M(-53.6%) | $35.25M(+6.5%) |
| Dec 2022 | $33.10M | $15.36M(+128.3%) | $33.10M(+46.4%) |
| Sep 2022 | - | $6.73M(+11.4%) | $22.61M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $6.04M(+21.5%) | $20.08M(+10.0%) |
| Mar 2022 | - | $4.97M(+2.3%) | $18.26M(+5.8%) |
| Dec 2021 | $17.25M(+227.3%) | $4.86M(+15.6%) | $17.25M(+15.0%) |
| Sep 2021 | - | $4.21M(-0.2%) | $14.99M(+27.9%) |
| Jun 2021 | - | $4.21M(+6.3%) | $11.73M(+36.5%) |
| Mar 2021 | - | $3.97M(+52.1%) | $8.59M(+63.0%) |
| Dec 2020 | $5.27M(+185.4%) | $2.61M(+178.3%) | $5.27M(+97.9%) |
| Sep 2020 | - | $937.00K(-13.2%) | $2.66M(+54.3%) |
| Jun 2020 | - | $1.08M(+67.2%) | $1.73M(+167.2%) |
| Mar 2020 | - | $646.00K | $646.00K |
| Dec 2019 | $1.85M(+101.2%) | - | - |
| Dec 2018 | $918.00K | - | - |
FAQ
- What is AbCellera Biologics Inc. annual depreciation & amortization?
- What is the all time high annual D&A for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual D&A year-on-year change?
- What is AbCellera Biologics Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly D&A year-on-year change?
- What is AbCellera Biologics Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM D&A year-on-year change?
What is AbCellera Biologics Inc. annual depreciation & amortization?
The current annual D&A of ABCL is $97.00M
What is the all time high annual D&A for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual depreciation & amortization is $97.00M
What is AbCellera Biologics Inc. annual D&A year-on-year change?
Over the past year, ABCL annual depreciation & amortization has changed by +$66.10M (+213.97%)
What is AbCellera Biologics Inc. quarterly depreciation & amortization?
The current quarterly D&A of ABCL is $6.61M
What is the all time high quarterly D&A for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly depreciation & amortization is $38.30M
What is AbCellera Biologics Inc. quarterly D&A year-on-year change?
Over the past year, ABCL quarterly depreciation & amortization has changed by -$161.00K (-2.38%)
What is AbCellera Biologics Inc. TTM depreciation & amortization?
The current TTM D&A of ABCL is $96.84M
What is the all time high TTM D&A for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM depreciation & amortization is $97.00M
What is AbCellera Biologics Inc. TTM D&A year-on-year change?
Over the past year, ABCL TTM depreciation & amortization has changed by +$66.30M (+217.08%)